EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 26.30
+1.15 (4.57%)
At close: Aug 14, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 776.63 million as of August 14, 2026. Its market cap has decreased by -68.75% in one year.
Market Cap
776.63M
Enterprise Value
1.18B
Revenue
432.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.30
ChartMarket Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 776.63M, an increase of 892.85%. That is a compound annual growth rate of 19.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 776.63M | -54.50% |
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.29B |
| Cereno Scientific AB | 1.50B |
| Nanexa AB | 854.64M |
| Dicot Pharma AB | 709.69M |
| Cinclus Pharma Holding AB | 558.45M |
| Orexo AB | 546.17M |
| Moberg Pharma AB | 535.81M |
| Enzymatica AB | 474.55M |